Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pediculus schaeffi

ABSTRACT: Pediculus schaeffi Genome sequencing

PROVIDER: PRJNA230884 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1182279_1.fastq.gz	Fastqsanger.gz
	SRR1182279_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Pediculus humanus capitis

Project description:Pediculus humanus capitis Genome sequencing

| PRJNA837756 | ENA

Pediculus schaeffi

Project description:Pediculus schaeffi overview

| PRJNA374358 | ENA

Pediculus humanus

Project description:Illumina Sequencing of Pediculus Humanus Mitochondrial Coding region

| PRJNA179337 | ENA

Pediculus humanus corporis strain:USDA

Project description:Genome sequencing of Pediculus humanus corporis strain USDA

| PRJNA16223 | ENA

Pediculus humanus capitis isolate:MI_2022

Project description:Pediculus humanus capitis isolate:MI_2022 Genome sequencing and assembly

| PRJNA855626 | ENA

Pediculus humanus capitis

Project description:Pediculus humanus capitis Transcriptome or Gene expression

| PRJNA392369 | ENA

Pediculus humanus capitis isolate:NM-2022

Project description:Pediculus humanus capitis isolate:NM-2022 Genome sequencing

| PRJNA863264 | ENA

Pediculus humanus corporis strain:Frisco

Project description:Pediculus humanus corporis strain:Frisco Transcriptome or Gene expression

| PRJNA975842 | ENA

Pediculus humanus capitis isolate:Human/ child | breed:in the hair

Project description:Pediculus humanus capitis isolate:Human/ child | breed:in the hair Genome sequencing

| PRJNA555072 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data